Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,389
datasets available to search
ShareScore release 0.9.0
Dataset results
1,389 results for “bladder cancer”
Adjuvant Intraarterial Chemotherapy Following Surgery to Treat Locally Advanced Bladder Cancer
ClinicalTrials.gov study NCT01627197. IPD Sharing: YES. Countries: 1. Publications: 0.
Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers
ClinicalTrials.gov study NCT04723121. IPD Sharing: NO. Countries: 1. Publications: 0.
Prospective Study of Adjuvant Radiotherapy in High Risk Bladder Cancer.
ClinicalTrials.gov study NCT03718741. IPD Sharing: NO. Countries: 1. Publications: 0.
Information Needs and Supportive Rehabilitation Over Time in Patients Undergoing Cystectomy in Bladder Cancer
ClinicalTrials.gov study NCT07180121. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD155 in Bladder Cancer
ClinicalTrials.gov study NCT03789682. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
ClinicalTrials.gov study NCT06427824. IPD Sharing: YES. Countries: 1. Publications: 0.
Evaluation of Safety, Tolerability and Response of ATO-101™ in Patients With Non-Muscle-Invasive Bladder Cancer (PERSEVERANCE EU)
ClinicalTrials.gov study NCT07260162. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT05982561. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HER2 Expression of HER2 Affibody-based PET/CT to Predict Response in Bladder Cancer Patients Treated With ADC
ClinicalTrials.gov study NCT06548529. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer
ClinicalTrials.gov study NCT07261592. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)
ClinicalTrials.gov study NCT06211764. IPD Sharing: YES. Countries: 14. Publications: 0.
Urine-DNA Biomarkers in Detecting Bladder Cancer
ClinicalTrials.gov study NCT03066310. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Determinants of Bladder Cancer Recurrence Study (The DETER Study)
ClinicalTrials.gov study NCT02400944. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Determine Possible Effects of Apalutamide, Compared to Placebo, on EGFR Expression in Patients With Non-muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT05521698. IPD Sharing: YES. Countries: 1. Publications: 0.
Quality of Life and Symptom Management in Patients With Bladder Cancer
ClinicalTrials.gov study NCT00772018. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT07130578. IPD Sharing: NO. Countries: 1. Publications: 0.
Preoperative Detection of Muscle Invasion in Bladder Cancer with Contrast-enhanced Ultrasonography
ClinicalTrials.gov study NCT05204108. IPD Sharing: NO. Countries: 1. Publications: 0.
Low Energy Shock Wave Therapy and Non-Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT04644835. IPD Sharing: NO. Countries: 1. Publications: 0.
Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)
ClinicalTrials.gov study NCT04700124. IPD Sharing: YES. Countries: 29. Publications: 0.
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
ClinicalTrials.gov study NCT06637423. IPD Sharing: YES. Countries: 6. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.